2018 ACIP建议 美国乙肝病毒感染的预防Prevention of Hepatitis B Virus Infection in the United States Recommendations of the Advisory Committee on Immunization Practices.PDFVIP

Morbidity and Mortality Weekly Report Recommendations and Reports / Vol. 67 / No. 1 January 12, 2018 Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices U.S. Department of Health and Human Services Centers for Disease Control and Prevention Recommendations and Reports CONTENTS Disclosure of Relationships Introduction 1 The 2016–2017 ACIP Hepatitis Vaccines Work Group members wish to disclose that they have no financial or New or Updated Recommendations 1 competing interests with the manufacturers of commercial Methods 2 products or suppliers of commercial services related to hepatitis B (HepB) vaccines. Content will not include any HBV Background 3 discussion of the unlabeled use of a product or a product under Prophylaxis Against HBV Infection 9 investigational use, with the following exceptions: Recommendations 13 • use of Pediarix vaccine for infants born to hepatitis B surface antigen (HBsAg)–positive mothers or mothers Future Directions 25 with an unknown HBsAg status to complete the vaccine Acknowledgments 25 series after receipt of a birth dose of single-antigen HepB References 25 vaccine and hepatiti